Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A
Series: International Review of Cell and Molecular Biology; 391;
- Publisher's listprice EUR 171.00
-
72 538 Ft (69 084 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 7 254 Ft off)
- Discounted price 65 284 Ft (62 176 Ft + 5% VAT)
72 538 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Academic Press
- Date of Publication 18 April 2025
- ISBN 9780443345296
- Binding Hardback
- No. of pages274 pages
- Size 229x152 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part A, Volume 391 delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Circulating biomarkers for diagnosis and response to therapies in cancer patients, Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients, Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients, Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer, and much more.
This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.
- Provides a comprehensive overview of circulating biomarkers used in cancer diagnosis, prognosis, and treatment response monitoring
- Discusses the clinical utility of circulating biomarkers in early cancer detection, prognostication, treatment selection, and monitoring therapeutic responses
- Explores the latest technologies and methodologies for the detection, quantification, and analysis of circulating biomarkers in cancer patients
Table of Contents:
Preface
Sheila Spada and Lorenzo Galluzzi
1. Circulating biomarkers for diagnosis and response to therapies in cancer patients
Natália Marcéli Stefanes, Maria Eduarda Cunha-Silva, Lisandra de Oliveira Silva,
Laura Otto Walter, Maria Cláudia Santos-Silva, and Manas Ranjan Gartia
2. Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients
Ronan W. Hsieh, Lynn K. Symonds, Jason Siu, and Stacey A. Cohen
3. Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients
Pooja Ratre, Suresh Thareja, Pradyumna Kumar Mishra
4. Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer
Sabareeswaran Krishnan, Shruthi Kanthaje, Punchappady Devasya Rekha,
M. Mujeeburahiman, and Chandrahas Koumar Ratnacaram
5. Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma
Queenie Fernandes, Abdul W. Ansari, Karama Makni-Maalej, Maysaloun Merhi,
Said Dermime, Aamir Ahmad, and Shahab Uddin
6. Nectin-4: A promising prognostic marker and therapeutic target in cancer
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, Zahwa Mariyam, Queenie Fernandes, Mohsin Maqbool, Omar M. Khan, Ajaz A. Bhat, and Shahab Uddi
Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A
